Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 31 May 1996:
Vol. 272. no. 5266, pp. 1258 - 0
DOI: 10.1126/science.272.5266.1258a
Prev | Table of Contents | Next

News & Comment

Robert F. Service

Hundreds of millions of couples worldwide lack adequate contraception, and this situation leads to over 50 million abortions each year, according to a new report by the U.S. Institute of Medicine. Yet pharmaceutical companies have all but abandoned R&D programs in this area. The report recommends several ways for the U.S. government, industry, and international health organizations to prod new research efforts. They include: reforming U.S. product liability law, including contraceptives in health insurance coverage, and pooling contraceptive purchasing funds from international health agencies to create a large market. But the report's authors as well as outside observers acknowledge that most of these recommendations will face stiff opposition.




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)